Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Immucell (ICCC) Other Working Capital Changes (2016 - 2025)

Historic Other Working Capital Changes for Immucell (ICCC) over the last 16 years, with Q3 2025 value amounting to $117643.0.

  • Immucell's Other Working Capital Changes rose 2939.6% to $117643.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $271721.0, marking a year-over-year increase of 19155.7%. This contributed to the annual value of -$93123.0 for FY2024, which is 20602.64% down from last year.
  • As of Q3 2025, Immucell's Other Working Capital Changes stood at $117643.0, which was up 2939.6% from -$151911.0 recorded in Q2 2025.
  • In the past 5 years, Immucell's Other Working Capital Changes ranged from a high of $327569.0 in Q1 2023 and a low of -$395632.0 during Q2 2024
  • In the last 5 years, Immucell's Other Working Capital Changes had a median value of $90917.0 in 2024 and averaged $13734.1.
  • Its Other Working Capital Changes has fluctuated over the past 5 years, first crashed by 17162.83% in 2021, then surged by 23308.83% in 2023.
  • Quarter analysis of 5 years shows Immucell's Other Working Capital Changes stood at -$195298.0 in 2021, then grew by 8.01% to -$179662.0 in 2022, then surged by 36.89% to -$113381.0 in 2023, then surged by 179.62% to $90274.0 in 2024, then soared by 30.32% to $117643.0 in 2025.
  • Its Other Working Capital Changes stands at $117643.0 for Q3 2025, versus -$151911.0 for Q2 2025 and $215715.0 for Q1 2025.